延迟折扣与抑郁相关但不预测抗抑郁药停药后复发
该多站点研究测量了97例缓解期重性抑郁障碍(MDD)患者在停用抗抑郁药(ADM)前及停药后6个月内的延迟折扣,并与54名无终生MDD的匹配对照比较。结果显示缓解期MDD组基线延迟折扣显著高于对照组(p<0.05;Cohen's d=0.34),且与抑郁评分正相关(Spearman ρ=0.24),但延迟折扣在停药后未增加,基线折扣或停药后变化均不预测6个月内抑郁复发。
要点
- 缓解期MDD患者基线延迟折扣显著高于对照(p<0.05;d=0.34)。
- 基线延迟折扣与抑郁评分呈正相关(Spearman ρ=0.24)。
- 延迟折扣不预测ADM停药后6个月内抑郁复发。
核心结论
- 延迟折扣在经抗抑郁药治疗的缓解期MDD中升高,但停药后不增加,也不前瞻性预测抑郁复发,提示其与停药后疾病轨迹关系不大。
研究设计与样本
- 多站点研究纳入缓解期MDD患者97例和无终生MDD的匹配对照54例,在停用ADM前及停药后6个月内测量延迟折扣并随访复发。
主要发现
- 缓解期MDD组基线延迟折扣显著高于对照组(p<0.05;Cohen's d=0.34)。
- 基线延迟折扣与抑郁评分呈正相关(Spearman ρ=0.24)。
- 延迟折扣在ADM停药后未增加,基线折扣或停药后变化均不预测后续抑郁复发。
关键数值与推荐
- 缓解期MDD组与对照组基线延迟折扣差异显著(p<0.05;Cohen's d=0.34)。
- 基线延迟折扣与抑郁评分正相关(Spearman ρ=0.24)。
临床怎么用
- 延迟折扣不宜作为ADM停药后抑郁复发的可靠预测指标。
- 对缓解期MDD患者,延迟折扣升高可能与抑郁症状相关,但需结合其他临床信息评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Approximately one third of people with Major Depressive Disorder (MDD) experience a relapse within six months of discontinuing antidepressant medication (ADM), however, reliable predictors of relapse following ADM discontinuation are currently lacking. A putative behavioural predictor is delay discounting, which measures a person's impatience to receive reward. Previous studies have linked delay discounting to both MDD and reduced serotonergic function, rendering it a plausible candidate predictor. In this multi-site study we measured delay discounting in participants with remitted MDD (N = 97), before and within six months after discontinuation of ADM, and in matched controls without a lifetime history of MDD (N = 54). Using predictive models, we tested whether either baseline discounting, or an early change in discounting following ADM discontinuation, predicted depressive relapse over a six month follow up period. We also tested differences between remitted MDD and control groups in delay discounting at baseline, and associations between discounting and depressive symptoms. We found that the remitted MDD group, compared to the control group, showed significantly higher (p < 0.05; Cohen's d = 0.34) discounting at baseline. In addition, baseline discounting was positively correlated with depression rating scores (Spearman ρ = 0.24). However, delay discounting did not increase following ADM discontinuation. Neither baseline discounting, nor a change in discounting following ADM discontinuation, predicted subsequent depressive relapse. We conclude that delay discounting is elevated in remitted MDD treated with antidepressant medication. However, delay discounting neither increases following ADM discontinuation, nor does it prospectively predict depressive relapse. These results suggest that delay discounting in Major Depressive Disorder has little relationship with illness trajectory following ADM discontinuation.
引用
- Elad D, Story GW, Berwian IM, et al. Delay discounting correlates with depression but does not predict relapse after antidepressant discontinuation. Mol Psychiatry. 2026. PMID: 41507345. doi:10.1038/s41380-025-03402-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。